
51 - 200 employés
Fondée en 2004
🧬 Biotechnologie
💊 Pharmaceutique
💰 €75 000 000 Post IPO equity en 2024-02
Biotechnology • Pharmaceuticals
Liquidia est une entreprise biopharmaceutique se concentrant sur le développement de thérapies inhalées pour les maladies cardiopulmonaires rares, en particulier l'hypertension artérielle pulmonaire (HTAP) et l'hypertension pulmonaire associée à une maladie pulmonaire interstitielle (HP-MPI). La société s'appuie sur sa technologie propriétaire d'ingénierie de particules PRINT® pour créer des formulations et des méthodes de livraison exclusives visant à améliorer l'efficacité, la tolérance et la commodité des médicaments inhalés ; son portefeuille comprend le trépostinil inhalé (produit commercial) et des candidats en phase clinique comme le L606. Liquidia met l'accent sur le soutien aux patients, le développement clinique et la progression des thérapies pour de meilleurs résultats respiratoires.
🕒 il y a 10 jours
🗣️🇺🇸🇬🇧 Anglais requis
D'où vient cette offre
Publiée sur la page carrières de Liquidia Corporation, pas via un site d'emploi
Repérée par Remote Rocketship il y a 10 jours
Toujours ouverte sur le site de Liquidia Corporation. Vérifiée il y a 31 minutes.

51 - 200 employés
Fondée en 2004
🧬 Biotechnologie
💊 Pharmaceutique
💰 €75 000 000 Post IPO equity en 2024-02
Biotechnology • Pharmaceuticals
Liquidia est une entreprise biopharmaceutique se concentrant sur le développement de thérapies inhalées pour les maladies cardiopulmonaires rares, en particulier l'hypertension artérielle pulmonaire (HTAP) et l'hypertension pulmonaire associée à une maladie pulmonaire interstitielle (HP-MPI). La société s'appuie sur sa technologie propriétaire d'ingénierie de particules PRINT® pour créer des formulations et des méthodes de livraison exclusives visant à améliorer l'efficacité, la tolérance et la commodité des médicaments inhalés ; son portefeuille comprend le trépostinil inhalé (produit commercial) et des candidats en phase clinique comme le L606. Liquidia met l'accent sur le soutien aux patients, le développement clinique et la progression des thérapies pour de meilleurs résultats respiratoires.
• Hire, coach, supervise, and develop the regional PAH Disease Specialist team • Manage sales professional development and performance management • Participate actively in strategic business planning for the region and each territory • Develop strong business relationships with top KOLs across the region • Plan strategic business meetings in the field and at medical conferences • Establish and maintain communication with cross-functional stakeholders across the Liquidia commercial organization • Develop and implement regional business plans • Manage the regional budget in alignment with regional and national expectations • Participate in new-hire training, launch meetings, National/POA sales meetings, and ongoing team training and development • Maintain clinical and technical expertise to accurately answer product, marketing, policy, and business-related questions • Ensure personal and team compliance with relevant laws, policies, and processes • Perform other job-related duties as determined by business needs • Lead the regional team to launch Yutrepia and sell Treprostinil Injection in the PAH marketplace • Report to the VP of US Sales • Drive regional sales performance and act as a product champion
• Bachelor’s Degree or equivalent • 3+ years of Cardiology, Pulmonary, or rare disease sales experience • PAH-HCP Relationships is a plus • Demonstrated experience delivering outstanding results and developing others to their potential • 2+ years of building and leading sales teams as a sales manager preferred • Launch Experience highly preferred • Experience formally coaching sales representatives in the field • Experience in developing and implementing regional business plans • Experience developing and leading sales training and sales meetings, either as a formal sales trainer or as a sales manager • Proven ability to successfully manage multiple tasks concurrently under aggressive timelines in a dynamic environment • Ability to generate insights from analytics, both interpreting reports and creating analyses from CRM and in Excel • Experience working with Specialty Pharmacy distributed therapies preferred • Experience strategizing within cross-functional teams, utilizing differential resources to achieve business goals • High social intelligence, integrity, and professionalism
• Competitive compensation package including base salary and commission • Medical insurance • Dental insurance • Vision insurance • Short-term disability (STD) • Long-term disability (LTD) • 401(k) Savings Retirement Plan • Employee Stock Purchase Plan (ESPP) • Unlimited Paid Time Off • Equal opportunity employment • Reasonable accommodation for qualified individuals with disabilities
Postuler MaintenantAméliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.
🕒 il y a 11 jours
Cyber Defense Director protecting Sony’s global entertainment and technology businesses. Leading detection, incident response, security engineering, and cyber risk operations.
🇺🇸 États-Unis – Télétravail
💵 $220 000 - $240 000 / an
💰 €700 000 000 Post IPO equity en 2024-08
⏰ Temps Plein
🔴 Expert
👔 Directeur
🗣️🇺🇸🇬🇧 Anglais requis
🗣️🇪🇸 Espagnol requis
🕒 il y a 11 jours
Director leading Molex’s magnetics product strategy, technology roadmaps, and new product development. Driving profitable growth across global data center, networking, industrial, and communications markets.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 11 jours
Director leading Barnes Aerospace’s North American continuous improvement strategy, governance, and deployment roadmap. Driving manufacturing transformation, financial benefits, and operational excellence across multiple sites.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 11 jours
Director of Subrogation leading subrogation strategy and recovery operations at Strala, an AI-native third-party administrator. Improving recoveries, claims workflows, teams, and client outcomes.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 11 jours
Global Safety Director leading pharmacovigilance strategy and periodic aggregate safety reports for Amgen’s biotech medicines. Managing global teams and regulatory compliance across the product life cycle.
🇺🇸 États-Unis – Télétravail
💵 $191 067 - $258 502 / an
💰 €28 500 000 000 Post-IPO Debt en 2022-12
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis